摘要
乳腺癌治疗失败的一个重要原因是代谢和细胞内稳态的机制受损,这使得很难预见相应的治疗反应。乳腺癌的靶向治疗取决于特定的分子如生长因子或激素受体的表达。许多类型的乳腺癌在凋亡途径中表现出不同的异常反应,这赋予了许多形式的对化疗的抵抗力。由于自噬在癌症发生发展过程及其对治疗反应的影响有着重要作用,这里已经对这一过程的分子调控和信号转导机制进行了大量的研究。在这里,我们总结了此前关于使用已批准用于与自噬调制/调节相关的靶向途径和因子,治疗不同的乳腺癌分子亚型的药物的不同的乳腺癌治疗策略的研究。
关键词: 自噬,乳腺癌,靶向治疗,受体,组蛋白去乙酰化酶,溶酶体,微管。
图形摘要
Current Cancer Drug Targets
Title:Autophagy as a Potential Therapeutic Target in Breast Cancer Treatment
Volume: 18 Issue: 7
关键词: 自噬,乳腺癌,靶向治疗,受体,组蛋白去乙酰化酶,溶酶体,微管。
摘要: One of the crucial reasons of breast cancer therapy failure is an impairment of mechanisms responsible for metabolism and cellular homeostasis, which makes it difficult to foresee the response to the treatment. Targeted therapy in breast cancer is dictated by the expression of specific molecules such as growth factor or hormone receptors. Many types of breast cancer exhibit different abnormalities in the apoptotic pathway, which confer the resistance to many forms of chemotherapy. Because of the fundamental importance of autophagy in the development and progression of cancer and its ability to affect treatment response, there has been an immense research on molecular regulation and signal transduction mechanisms that control this process. Here, we summarize the present knowledge concerning different breast cancer treatment strategies using drugs approved for the treatment of different breast cancer molecular subtypes with targeting pathways and factors associated with autophagy modulation/ regulation.
Export Options
About this article
Cite this article as:
Autophagy as a Potential Therapeutic Target in Breast Cancer Treatment, Current Cancer Drug Targets 2018; 18 (7) . https://dx.doi.org/10.2174/1568009617666171114143330
DOI https://dx.doi.org/10.2174/1568009617666171114143330 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
GMDR: Versatile Software for Detecting Gene-Gene and Gene-Environment Interactions Underlying Complex Traits
Current Genomics Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Current Cancer Drug Targets Medicinal Plants for the Prevention and Treatment of Bacterial Infections
Current Pharmaceutical Design Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines
Anti-Cancer Agents in Medicinal Chemistry A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy
Current Cancer Therapy Reviews The Role of a Human Hematopoietic Mesenchymal Progenitor in Wound Healing and Fibrotic Diseases and Implications for Therapy
Current Stem Cell Research & Therapy Role of miR-193a in Cancer: Complexity and Factors Control the Pattern of its Expression
Current Cancer Drug Targets Platelet Biomarkers in Tumor Growth
Current Proteomics AMPK: Therapeutic Target for Diabetes and Cancer Prevention
Current Pharmaceutical Design Omentin: Linking Metabolic Syndrome and Cardiovascular Disease
Current Vascular Pharmacology Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel and Emerging Targeted Therapies of Colorectal Cancer
Current Clinical Pharmacology Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization
Current Topics in Medicinal Chemistry NAD Precursors, Mitochondria Targeting Compounds and ADP-Ribosylation Inhibitors in Treatment of Inflammatory Diseases and Cancer
Current Medicinal Chemistry Quantitative Proteomics for Cancer Biomarker Discovery
Combinatorial Chemistry & High Throughput Screening Current Treatments of Primary Sclerosing Cholangitis
Current Medicinal Chemistry Evaluation of the Risk/Benefit Ratio of Old and New Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Exploring Patterns of Epigenetic Information with Data Mining Techniques
Current Pharmaceutical Design Advancement of Traditional Chinese Medicine in Regulation of Intestinal Flora: Mechanism-based Role in Disease Management
Recent Patents on Anti-Cancer Drug Discovery Inhibition of Disulfide Reductases as a Therapeutic Strategy
Current Enzyme Inhibition